240 related articles for article (PubMed ID: 31168824)
1. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
[TBL] [Abstract][Full Text] [Related]
2. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling.
Wang R; Du Y; Shang J; Dang X; Niu G
Mol Cell Probes; 2020 Oct; 53():101642. PubMed ID: 32645410
[TBL] [Abstract][Full Text] [Related]
3. PTPN14 interacts with and negatively regulates the oncogenic function of YAP.
Liu X; Yang N; Figel SA; Wilson KE; Morrison CD; Gelman IH; Zhang J
Oncogene; 2013 Mar; 32(10):1266-73. PubMed ID: 22525271
[TBL] [Abstract][Full Text] [Related]
4. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity.
Michaloglou C; Lehmann W; Martin T; Delaunay C; Hueber A; Barys L; Niu H; Billy E; Wartmann M; Ito M; Wilson CJ; Digan ME; Bauer A; Voshol H; Christofori G; Sellers WR; Hofmann F; Schmelzle T
PLoS One; 2013; 8(4):e61916. PubMed ID: 23613971
[TBL] [Abstract][Full Text] [Related]
6. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.
Huang JM; Nagatomo I; Suzuki E; Mizuno T; Kumagai T; Berezov A; Zhang H; Karlan B; Greene MI; Wang Q
Oncogene; 2013 Apr; 32(17):2220-9. PubMed ID: 22689061
[TBL] [Abstract][Full Text] [Related]
7. PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function.
Wilson KE; Li YW; Yang N; Shen H; Orillion AR; Zhang J
J Biol Chem; 2014 Aug; 289(34):23693-700. PubMed ID: 25023289
[TBL] [Abstract][Full Text] [Related]
8. microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer.
Chen G; Yang Z; Feng M; Wang Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793993
[TBL] [Abstract][Full Text] [Related]
9. Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling.
Wang S; Ping M; Song B; Guo Y; Li Y; Jia J
Yonsei Med J; 2020 Sep; 61(9):750-761. PubMed ID: 32882759
[TBL] [Abstract][Full Text] [Related]
10. PTPN14, a target gene of miR-4295, restricts the growth and invasion of osteosarcoma cells through inactivation of YAP1 signalling.
Liang G; Duan C; He J; Ma W; Dai X
Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1301-1310. PubMed ID: 32141101
[TBL] [Abstract][Full Text] [Related]
11. PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes.
Bottini A; Wu DJ; Ai R; Le Roux M; Bartok B; Bombardieri M; Doody KM; Zhang V; Sacchetti C; Zoccheddu M; Lonic A; Li X; Boyle DL; Hammaker D; Meng TC; Liu L; Corr M; Stanford SM; Lewis M; Wang W; Firestein GS; Khew-Goodall Y; Pitzalis C; Bottini N
Ann Rheum Dis; 2019 May; 78(5):600-609. PubMed ID: 30808624
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
Liu YP; Sun XH; Cao XL; Jiang WW; Wang XX; Zhang YF; Wang JL
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1759-1767. PubMed ID: 28485805
[TBL] [Abstract][Full Text] [Related]
14. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.
Zhang J; Xu ZP; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(3):583-90. PubMed ID: 23058008
[TBL] [Abstract][Full Text] [Related]
15. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
16. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
18. Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.
Po'uha ST; Le Grand M; Brandl MB; Gifford AJ; Goodall GJ; Khew-Goodall Y; Kavallaris M
Br J Cancer; 2020 Feb; 122(3):434-444. PubMed ID: 31806880
[TBL] [Abstract][Full Text] [Related]
19. PTPN14 is required for the density-dependent control of YAP1.
Wang W; Huang J; Wang X; Yuan J; Li X; Feng L; Park JI; Chen J
Genes Dev; 2012 Sep; 26(17):1959-71. PubMed ID: 22948661
[TBL] [Abstract][Full Text] [Related]
20. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.
Yang Y; Ma Q; Li Z; Wang H; Zhang C; Liu Y; Li B; Wang Y; Cui Q; Xue F; Ai D; Zhu Y; He J
Br J Pharmacol; 2021 Apr; 178(7):1524-1540. PubMed ID: 33474722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
